Advanced search
Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 31, 2024 - Issue 2
Submit an article Journal homepage
1,110
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Serum neurofilament light chain in hereditary transthyretin amyloidosis: validation in real-life practice

Antonia S. Carrolla Brain and Mind Centre, Faculty of Medicine and Health, Translational Research Collective University of Sydney and Department of Neurology, Royal Prince Alfred Hospital, Sydney, Australia;b Centre for Neuromuscular disease, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UKCorrespondence[email protected]
View further author information
,
Yousuf Razvic National Amyloidosis Centre, UCL Division of Medicine, Royal Free Hospital, London, UKView further author information
,
Luke O’Donnellb Centre for Neuromuscular disease, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UKView further author information
,
Elena Velevad UK Dementia Research Institute at UCL, London, UKView further author information
,
Amanda Heslegraved UK Dementia Research Institute at UCL, London, UK;e Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UKView further author information
,
Henrik Zetterbergd UK Dementia Research Institute at UCL, London, UK;e Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK;f Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden;g Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden;h Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China;i WI Alzheimer’s Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USAView further author information
,
Steve Vucicj Brain and Nerve Research Centre, Concord Hospital, University of Sydney, Sydney, AustraliaView further author information
,
Matthew C. Kiernana Brain and Mind Centre, Faculty of Medicine and Health, Translational Research Collective University of Sydney and Department of Neurology, Royal Prince Alfred Hospital, Sydney, AustraliaView further author information
,
Alexander M. Rossorb Centre for Neuromuscular disease, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UKView further author information
,
Julian D. Gillmorec National Amyloidosis Centre, UCL Division of Medicine, Royal Free Hospital, London, UKView further author information
&
Mary M. Reillyb Centre for Neuromuscular disease, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UKView further author information
 show all
Pages 95-104 | Received 08 Nov 2023, Accepted 27 Jan 2024, Published online: 13 Feb 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.